RNA Interference Screening Identifies Lenalidomide Sensitizers in Multiple Myeloma, Including RSK2
Blood - United States
doi 10.1182/blood-2014-05-577130
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2015
Authors
Publisher
American Society of Hematology